Home / Clinics Supported / Hormone Optimization / Women's Health
Open a Women's Health Clinic for a
Market That's Finally Being Heard.
The menopause conversation has reached the mainstream. HRT demand is accelerating faster than the existing system can meet it, and most markets have no dedicated women's hormone health clinic. ACG builds the one that should have been there years ago. No medical background is required to own the business; an independent, state-licensed Medical Director directs all clinical care.
Book a Strategy CallA Mainstream Conversation
With No Local Answer
The cultural conversation around women's hormone health, menopause, perimenopause, BHRT, libido, energy, and body composition, has reached mainstream awareness. Major media coverage and a generation of women who expect real answers have driven search volume to levels the existing system cannot absorb.
HRT clinic searches reach 165,000 per month in the U.S. Perimenopause-related search volume is growing year over year. Most markets have no dedicated women's hormone health clinic answering these searches locally.
The woman searching for hormone support is not looking for a 15-minute appointment and a prescription. She is looking for a clinic that understands her, monitors her, and adjusts with her over time. That relationship, built correctly, has among the highest lifetime value of any patient in cash-pay health.
ACG has been building women's hormone clinics since before the mainstream conversation caught up. The compliance infrastructure, the BHRT pharmacy relationships, and the marketing frameworks are already built.
Representative of broader category trends. Local demand varies by market.
What a Women's Hormone Clinic Offers
The protocol stack that creates the ongoing patient relationship, and the adjacencies that expand it.
Pellet, cream, and injectable BHRT protocols for estrogen, progesterone, and testosterone optimization, compounded through vetted 503A pharmacies. The category anchor for women's hormone health.
Comprehensive hormone panel monitoring, symptom tracking, and protocol adjustment for the full perimenopause to post-menopause journey.
Sermorelin, prescriber-directed and documented, is the defensible growth hormone adjunct alongside BHRT. The compounds patients read about, CJC-1295 and ipamorelin among them, are not on the 503A Bulks List and cannot be lawfully compounded. See our Peptide Therapy page for the full compound status table.
Libido and intimacy support delivered as part of the BHRT patient relationship, including PRP-based procedures for the enrolled patient experiencing hormone-related changes. Note that several branded protocol names in this space are registered trademarks requiring licensing. For dedicated sexual wellness clinics covering the full service menu, see our Sexual Wellness page.
Body composition monitoring, metabolic panel tracking, and FDA-approved GLP-1 adjacency for the BHRT patient experiencing weight changes through hormonal transitions. See our Metabolic Weight Loss page for the full model.
Ongoing labs and quarterly check-ins that create the sustained patient relationship, and the recurring revenue, that makes women's hormone health a high-LTV category.
BHRT Compliance Is
Specific and Navigable
Bioidentical hormone replacement therapy is prescribed through compounding pharmacies, which requires specific pharmacy vetting, prescribing structure, and Medical Director oversight. State-by-state variation in prescribing authority affects how the clinical framework is built.
Branded procedure names are a live exposure in this category. Several of the well-known protocol names are registered trademarks owned by their originators, and using them typically requires training and licensing. ACG builds your service descriptions on generic clinical language unless you hold the license.
Marketing for women's hormone health also has platform-specific restrictions. ACG builds compliant patient acquisition from day one, before the first campaign is submitted for review.
Pre-vetted compounding pharmacy partners for estrogen, progesterone, and testosterone compounds at preferred pricing.
Vetted MDs with experience in women's hormone health across all 50 states. ACG coordinates the supervision agreement.
Women's hormone health informed consent frameworks and clinical protocols established before your first patient.
Service names, procedure descriptions, and marketing copy reviewed against trademark exposure and platform advertising rules before anything goes live.
60 days of continued ACG support after opening, patient flow, protocol adjustment, marketing optimization.
Answers Before
You Open.
Operators looking at women's hormones want straight answers on BHRT compliance, prescriber sourcing, what services to launch with, and how to reach this demographic on Meta and Google. Honest answers below.
If something isn't covered here, that's what the consultation is for. No pressure, no pitch.
View All FAQsWhat does a women's hormone clinic typically offer?
Is BHRT compliant for cash-pay clinics?
Can I use the branded procedure names I see other clinics advertising?
Do I need to be a physician, or have an OB/GYN as Medical Director?
Can a women's hormone clinic operate telehealth-only?
How are women's hormone clinics typically marketed?
What's the typical pricing model for a women's hormone clinic?
How long does it take for a new patient to see results?
The Women's Hormone Clinic
Your Market Has Been Waiting For.
Book a free 30-minute strategy call. ACG will walk you through the women's hormone health opportunity in your market. BHRT compliance, pharmacy access, patient acquisition, and what the launch process looks like from day one.
Book a Strategy CallFree 30-minute call · No pitch · ACG works with a select number of clients at any given time
Structured to keep you on the right side of the line.
Regenerative health is one of the most heavily scrutinized spaces in medicine. Knowing the rules is not a footnote to what we do. It is the foundation. Here is how we structure every clinic we help launch.
Your Medical Director Directs Care
You own and operate the business. Every clinical, prescribing, and treatment decision is made by an independent, state-licensed Medical Director, structured to respect Corporate Practice of Medicine laws in your state. We connect you to a vetted network; you retain your own provider.
We Know the Regulatory Lines
PRP, peptides, GLP-1 medications, and cellular products each carry their own federal and state rules, and not every product or use is FDA-approved. Some, like exosomes for therapeutic use, are not FDA-approved at all, and we steer you away from them. We help you build a treatment menu on defensible, compliant options and a marketing approach that holds up to FDA, FTC, and state medical board scrutiny.
No Hype. No Guarantees.
We show you real ranges, not fantasy numbers, and we never promise an income or a clinical outcome. What you earn depends on your market, your capital, and your execution. We would rather set honest expectations than sell you a dream.
Altos Consulting Group is a business consulting and advisory firm, not a medical practice, and does not provide, prescribe, or sell any drug, biologic, device, or therapy. The FDA has stated there are currently no FDA-approved exosome products for the treatment of any disease; clinic owners are responsible for the regulatory compliance of every product, therapy, and claim. See our full regulatory notice below.